An Innovative Approach to Fix the Generic Drug Shortage

An Innovative Approach to Fix the Generic Drug Shortage

Most physicians are increasingly forced to grapple with the problem of shortages in generic drugs. These are drugs for which the patent has expired and any company can make them. Certainly for those of us in the PICU, it is a chronic problem because the majority of drugs we use are injectable medications that have […]

Your prescription drug coverage and medication questions answered

Your prescription drug coverage and medication questions answered

© Brandpoint © Brandpoint (BPT) – Prescription drug coverage and medications can be complex territory. Enter UnitedHealthcare Medicare & Retirement’s Chief Pharmacy Officer Mike Anderson, PharmD, who has spent his career navigating the ins and outs of the Rx world. Below, Anderson answers some questions people frequently ask about drug coverage and prescriptions. Q. What’s […]

US Generic Drug Market Overview 2018: Size, Share, Growth, Trends, Competitive Landscape, Opportunities and …

US Generic Drug Market Overview 2018: Size, Share, Growth, Trends, Competitive Landscape, Opportunities and …

“U.S. Generic Drug Market Bolstered by Government Support” Over the recent years, the U.S. generic drug market has been witnessing an impressive growth. Some of the factors which have given boost to the market include government initiatives, low capital investment, rising geriatric population and increasing cases of chronic diseases. Generic drugs are identical copies of […]

What's in the Administration's 5-Part Plan for Medicare Part D and What Would it Mean for Beneficiaries and Program …

What's in the Administration's 5-Part Plan for Medicare Part D and What Would it Mean for Beneficiaries and Program …

Introduction Today more than 43 million older adults and people with disabilities have prescription drug coverage under Medicare Part D. Part D helps people with Medicare afford their medications by subsidizing the purchase of drug coverage from private stand-alone prescription drug plans (PDPs) and Medicare Advantage drug plans (MA-PDs), and offering additional financial help to […]

MACPAC proposes changes to Medicaid drug rebate program

MACPAC proposes changes to Medicaid drug rebate program

The Medicaid and CHIP Payment and Access Commission called on Congress to make key changes to the Medicaid drug rebate program to cut spending on drugs for low-income people. Under the program, Medicaid covers drugs if the pharmaceutical companies are willing to have a national rebate agreement with HHS. Manufacturers must pay a rebate on […]

8 Reasons You're Overpaying for Healthcare

8 Reasons You're Overpaying for Healthcare

No matter your stage of life, there’s a good chance healthcare constitutes one of your most significant expenses. And if you’re struggling to keep up with it, you’re not alone. Medical debt is actually the No. 1 source of personal bankruptcy filings in the country, and even folks with decent insurance often find themselves in […]

Generic Drug Review Machinery Getting a Tune-Up

LAWS FDA is more than a year into an Action Plan to push more generic drugs through its approval system more quickly. A pioneer drug is the first one to gain FDA approval for a particular chemical for a particular use, and generics have the same chemical and use but are made by other companies, […]

Views CREATES Act will lower prescription drug costs

Views CREATES Act will lower prescription drug costs

Everyone should be able to get affordable coverage and care. Businesses, insurance providers, doctors, hospitals, and others continue to work on new ways to reverse healthcare cost trends, as we help patients get better faster — and stay healthier longer. Prescription drug costs have been a particular challenge, as they continue to represent the greatest […]

Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses

Study introduces novel strategy to obtain reasonable drug cost estimates for cost-effectiveness analyses

June 19, 2018 Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of a study introducing a novel strategy for obtaining reasonable drug cost estimates for US-based cost-effectiveness analyses. The report, A Transparent and Consistent Approach to Assess US Outpatient Drug Costs for […]

1 2 3 40